文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

自动化闭环通气与程序化常规通气对重症成人无呼吸机天数的影响:一项随机临床试验

Effect of Automated Closed-Loop Ventilation vs Protocolized Conventional Ventilation on Ventilator-Free Days in Critically Ill Adults: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2026-01-01
一句话结论在重症成人有创通气中,早期使用自动化闭环通气系统并未较程序化常规通气增加第28天无呼吸机天数(16.7 vs 16.3天,OR 0.91,95%CI 0.77-1.06,P=0.23)。

这项国际多中心随机临床试验在荷兰和瑞士7个ICU纳入有创通气开始不足1小时且预期需通气至少24小时的成人患者,随机接受INTELLiVENT自适应支持通气闭环通气(n=602)或程序化常规通气(n=599),两组均遵循标准化通气、镇静和撤机方案。主要终点第28天无呼吸机天数中位数闭环组16.7天(IQR 0.0-26.1)vs 常规组16.3天(IQR 0.0-26.5),OR 0.91(95%CI 0.77-1.06,P=0.23),无统计学差异。两组在主要终点各组分(幸存者通气时长和28天死亡率)及除通气质量外的次要终点均无差异,闭环组通气质量更高;严重高碳酸血症和低氧血症在闭环组更少见,需要补救治疗(主要是俯卧位)的患者更少,但多重性校正后未达统计学显著。作者结论认为,在重症成人有创机械通气中,早期使用自动化闭环通气系统并未较程序化常规通气增加第28天无呼吸机天数。

要点

  • 主要终点第28天无呼吸机天数:闭环通气组中位16.7天(IQR 0.0-26.1)vs 常规通气组16.3天(IQR 0.0-26.5),OR 0.91(95%CI 0.77-1.06,P=0.23),无统计学差异。
  • 主要终点各组分无差异:幸存者通气时长和28天死亡率两组间均无差异。
  • 次要终点除通气质量外均无差异,闭环通气组通气质量更高。
  • 闭环组严重高碳酸血症和低氧血症更少见,需要补救治疗(主要是俯卧位)的患者更少,但多重性校正后未达统计学显著。
  • 研究纳入有创通气开始不足1小时、预期需通气至少24小时的成人患者,两组均遵循标准化通气、镇静和撤机方案。

适用人群与场景

  • 荷兰和瑞士7个ICU的成人患者,有创通气开始不足1小时且预期需要通气24小时或以上,于2020年10月至2025年6月入组,最终随访至90天完成。

诊断标准与关键阈值

  • 主要终点第28天无呼吸机天数定义为存活且未使用有创通气的天数。

处置流程与药物剂量

  • 闭环通气组使用INTELLiVENT自适应支持通气(n=602),常规通气组使用程序化常规通气(n=599),两组均遵循标准化通气管理、镇静和撤机方案。

研究设计与关键结果

  • 国际多中心随机临床试验,7个ICU,1514例随机患者中1201例(79%)纳入改良意向治疗分析(女性36%;中位年龄63岁)。
  • 主要终点第28天无呼吸机天数:闭环通气组中位16.7天(IQR 0.0-26.1)vs 常规通气组16.3天(IQR 0.0-26.5),OR 0.91(95%CI 0.77-1.06,P=0.23)。
  • 主要终点各组分(幸存者通气时长和28天死亡率)两组间无差异。
  • 除通气质量外,次要终点两组间无差异;闭环通气组通气质量更高。
  • 闭环组严重高碳酸血症和低氧血症更少见,需要补救治疗(主要是俯卧位)的患者更少,多重性校正后未达统计学显著。

证据类型、等级与局限

  • 证据类型:国际多中心随机临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于有创通气开始不足1小时且预期需通气至少24小时的成人ICU患者,早期使用自动化闭环通气系统并未较程序化常规通气增加第28天无呼吸机天数,两组均遵循标准化通气、镇静和撤机方案。
  • 闭环通气组通气质量更高,严重高碳酸血症和低氧血症更少见、需要补救治疗(主要是俯卧位)的患者更少,但多重性校正后未达统计学显著。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Automated closed-loop ventilation systems continuously adjust ventilator settings based on real-time physiologic feedback and may optimize lung-protective ventilation. Their effect on patient-centered outcomes in critically ill patients receiving ventilation remains uncertain.

OBJECTIVE: To determine whether early initiation of automated closed-loop ventilation increases ventilator-free days at day 28 compared with protocolized conventional ventilation.

DESIGN, SETTING, AND PARTICIPANTS: International, multicenter, randomized clinical trial conducted at 7 intensive care units (ICUs) in the Netherlands and Switzerland. Adult patients with less than 1 hour elapsed after initiation of invasive ventilation and expected to require ventilation for 24 hours or longer were enrolled between October 2020 and June 2025, with final follow-up completed at 90 days.

INTERVENTIONS: Patients were randomly assigned (1:1) to receive automated closed-loop ventilation using INTELLiVENT adaptive support ventilation (n = 602) or protocolized conventional ventilation (n = 599). Both groups followed standardized ventilation management, sedation, and weaning protocols.

MAIN OUTCOMES AND MEASURES: The primary outcome was the number of ventilator-free days at day 28, defined as days alive and free from invasive ventilation. Secondary outcomes included mortality, duration of ventilation among survivors, ICU and hospital lengths of stay, and ventilation quality. Safety outcomes included severe hypoxemia, hypercapnia, and need for rescue therapies, including prone positioning, recruitment maneuvers, or bronchoscopy.

RESULTS: Among 1514 randomized patients, 1201 (79%) were included in the modified intention-to-treat analysis (36% women; median age, 63 years). The median of ventilator-free days at day 28 was 16.7 days (IQR, 0.0-26.1 days) in the closed-loop ventilation group and 16.3 days (IQR, 0.0-26.5 days) in the conventional ventilation group (odds ratio, 0.91; 95% CI, 0.77-1.06; P = .23). There were no differences between groups in components of the primary outcome, ie, duration of ventilation in survivors and 28-day mortality. There were no differences in secondary outcomes except for ventilation quality, which was higher with closed-loop ventilation. Severe hypercapnia and hypoxemia were less frequent in the closed-loop group, and fewer patients required rescue therapies, primarily prone positioning, compared with the conventional group (non-statistically significant after multiplicity adjustment).

CONCLUSIONS AND RELEVANCE: Among critically ill adults receiving invasive mechanical ventilation, early use of an automated closed-loop ventilation system did not increase ventilator-free days at day 28 compared with protocolized conventional ventilation.

TRIAL REGISTRATION: Clinicaltrials.gov Identifier: NCT04593810.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Sinnige JS, Buiteman-Kruizinga LA, Horn J, et al. Effect of Automated Closed-Loop Ventilation vs Protocolized Conventional Ventilation on Ventilator-Free Days in Critically Ill Adults: A Randomized Clinical Trial. JAMA. 2026. PMID: 41361939. doi:10.1001/jama.2025.24384

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。